In China, over 40 species of the genus Salvia have been used as medicinal plants for various diseases, some for thousands of years. Recently, research has focused on the biological activities of Salvia medicinal plants used in traditional chinese medicine (TCM). However, to date a scientific survey of the genus Salvia in China has not been carried out. In this paper, we report the results of 10 field surveys of Salvia medicinal plants collected in 17 provinces including detailed information on their local names, growing environment, distribution and therapeutic effects. We also summarize the results of research on the materia medica, phytochemistry and pharmacology of some of the important Salvia medicinal plants. Our study reveals that 35 Salvia plants have been used in TCM in different regions of China, including 20 species used as Danshen to treat heart diseases, and 15 species used to treat a range of other conditions including gynecological diseases, muscular or skeletal problems, hepatitis, urological diseases, and mouth and eye conditions. It is clear that some species of Salvia L. possess significant pharmacological activity in the context of ethnopharmacological knowledge, especially in the treatment of heart disease. Further studies of the phytochemistry and pharmacology of Salvia species will no doubt improve their medical utilization and contribute to the development of new natural drugs.
Introduction
Salvia L. species constitute the largest genus in the family Lamiaceae with over 1000 species distributed mainly in Central and South America (500 spp.), Central Asia/Mediterranean (250 spp.) and Eastern Asia (100 spp.). Most species are perennial herbs but annuals, shrubs and a few trees and vines also exist 1 . 84 Salvia species are native to China with their distribution located in South-West China, notably in the Hengduan Mountain region 2 . Salvia species have been used in herbal medicine for thousands of years. In fact, the name Salvia comes from the Latin word "salvare" meaning "to heal" and S. officinalis (Sage) has long been an important herb in Europe. Salvia species have been used in the treatment of more than sixty different ailments ranging from aches and pains to epilepsy although their main application has been in treating colds, bronchitis, tuberculosis, hemorrhage and menstrual disorders 3 . Until the discovery of antibiotics, Sage was a frequent ingredient of herbal teas recommended to patients with tuberculosis to prevent sudation. The leaves of Sage exhibit a range of biological activities based on their astringency and antibacterial, micostatic, virustatic and antihidrotic properties and are included in the British Herbal Pharmacopoeia (1983) for use as a gargle or mouthwash. Sage has also been included in combined herbal preparations for treating acute and chronic bronchitis 4 . In China, over 40 species of Salvia have been used as medicinal plants for various diseases, some for thousands of years. One of the most well-known herbs is the roots of S. miltiorrhiza Bunge (Red Sage, called Danshen in Chinese) which is endemic to Eastern Asia, and is included as an official drug in the Chinese Pharmacopeia (2010). Traditionally Danshen has been used to promote blood circulation, remove stagnation, tranquilize the mind, clear heat from the blood and resolve swelling 5 . In more recent times, the most important and frequent clinical use of Danshen has been in the treatment of coronary heart disease for the alleviation of angina pectoris, coronary artery spasm and myocardial infarction 6, 7 .
Although there is increasing interest in the biological activity of Salvia species 8, 9 , to date a scientific survey of the genus Salvia in China has not been reported. Given that the indigenous uses of many Salvia medicinal plants remain undocumented, we undertook the survey to collect information relating to the resource and use of Salvia plants in Traditional Chinese Medicine (TCM) in order to provide baseline data for future pharmacological and phytochemical studies.
Materials and methods
During the period 2006-2011, we conducted 10 field surveys in 17 provinces and regions of China (Beijing, Hebei, Henan, Shandong, Anhui, Jiangsu, Zhejiang, Hubei, Hunan, Jiangxi, Fujian, Shanxi, Gansu, Chongqing, Sichuan, Guangxi and Yunnan provinces) based on analysis of ancient medicinal works and local knowledge of herbal medicines that include Salvia species. With the assistance of local herbalists, we collected plant samples and recorded detailed information on their local names, growing environment, distribution and therapeutic effects (Table 1) . Voucher specimens of each plant species were identified by professional experts and their scientific names confirmed by consulting the Flora of China 2 . The specimens were pressed and deposited at the Pharmaphylogeny Laboratory of the Institute of Medicinal Plant Development, Chinese academy of Medical Sciences, and the Molecular Pharmacognosy Laboratory of the Institute of Chinese Materia Medica, China Academy of Traditional Chinese Medicine.
Results and discussion
In the Flora of China, Chinese Salvia species are classified into four subgenera namely Salvia, Sclarea, Jungia and Allagospadonopsis
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. Table 1 lists the species identified in this study arranged according to this classification system together with their local names, collection location, growing environment and therapeutic use.
Ethnopharmacological investigation
According to our field survey, 35 Salvia plants have been used as folk medicine in multiple therapeutic remedies in different regions of China. All four subgenera are represented with Sclarea (15) being the dominant subgenus, followed by Salvia (12), Allagospadonopsis (6) and Jungia (2).
Of the 35 Salvia species identified, 20 are used as Danshen to treat heart disease, 7 are used to treat respiratory diseases (cough, pneumonia and tracheitis), 8 for gynecological diseases (mastitis, dysmenorrheal and irregular menstruation), 2 for muscular or skeletal problems (muscular twitching pain and rheumatic arthritis), 3 for hepatitis, 2 for urological diseases (nephritis and urethritis), 2 for mouth and eye conditions (keratitis, faucitis and toothache), and 5 for other conditions (snakebite, sexual dysfunction, fever, hypertension and pyogenic infection of the skin) (Fig. 1A) .
Parts of Salvia species used in the preparation of herbal remedies were the roots (20 species), herbs (14 species), leaves (2 species), flowers (2 species), seeds (1 species) and fruits (1 species) (Fig. 1B) . It is well known that different parts of plants contain different concentrations of active constituents and different phytochemicals 11 . For example, flavonoids, triterpenoids and monoterpenes are found in the aerial parts of Salvia plants particularly the flowers and leaves, whereas diterpenoids and phenolic acids are mainly found in the roots 3 . In our survey, it emerged that, generally, only one part of a medicinal plant is used in the preparation of a particular herbal remedy. For example, the herbs of S. roborowskii are used to treat hepatitis, while its flowers are employed to treat toothache. Sometimes Salvia plants have been used as the sole ingredient in a herbal medicine but often they are used in combination with more than one medicinal plant. For example, the leaves of S. officinalis are used in a tea to prevent and treat hypertension whereas the roots of S. miltiorrhiza and its related species are used in combination with other herbal medicines (Rhizoma ligustici wallichii, Radix astragalus, Radix notoginseng) for the management of heart disease.
Decoctions or infusions are most commonly used for oral administration and only one species, S. cavaleriei, has been prepared for external use involving topical application of its crushed leaves to the site of pyogenic infection.
Details of some widely used Chinese Salvia species
According to our field survey, ethnopharmacological knowledge of Chinese Salvia species is indicative of their pharmacological activity especially in the treatment of heart disease and cancer. Based on the limited research into their phytochemistry and pharmacology, only those Salvia species of significant medicinal value are described below. The roots were used as Danshen. The herbs and seeds could be used to treat irregular menstruation. The roots were used as Danshen.
S. digitaloides
An ethnopharmacological investigation of medicinal Salvia plants (Lamiaceae) in China The herbs were used to treat hepatitis, dysmenorrhea and acute mastitis. In the ancient texts, the curative properties of Danshen were to promote blood circulation, remove stagnation, tranquilize the mind, clear heat from the blood and resolve swelling. In terms of morphology, the original species were described as roots red or purple and leaves comprising 5 or 7 leaflets opposited with the spica made up of purple flowers. In many ancient texts 12, 13 , the morphological characteristics were appropriate for many Salvia plant such as S. plectranthoides, S. yunnanensis and S. trijuga (Fig. 2) .
According to the results of our ethnopharmacological investigation, about 20 species of Salvia L. have been used as Danshen for the treatment of coronary heart disease and stroke. Based on their morphological characteristics and geographical distribution, these Danshen related species are divided into 2 groups. Group 1 comprises 11 species S. bulleyana, S. brachyloma, S. campanulata, S. castanea, S. digitaloides, S. evansiana, S. flava, S. kiaometiensis, S. przewalskii, S. trijuga and S. yunnaensis; Group 2 comprises 9 species namely S. bowleyana, S. dabieshanensis, S. honania, S. meiliensis, S. miltiorrhiza, S. paramiltiorrhiza, S. plectranthoides, S. sinica and S. vasta.
Most Danshen related species (except S. trijuga and S. yunnanensis) in Group 1 come from sect. Euryspace, and are mainly distributed in the plateau area at 2500-4000 m above sea level in Sichuan and Yunnan provinces of South-West China.
S. przewalskii in this group has been widely used and is commercially available in the local herbal markets of Sichuan, Yunnan and Gansu provinces. The geographical distribution and resources of other Danshen related species in Group 1 are limited and their applications in folk medicine are restricted to remote mountain areas and minority regions of Sichuan and Yunnan provinces. In addition, some Danshen related species have been applied for other therapeutic effects in different regions. For example, the roots of S. przewalskii have been employed to treat rheumatism in the West of Sichuan province and the roots of S. trijuga have been used as a tonic in the West of Yunnan province.
All Danshen related species in Group 2 are from sect. Drymophace, and are distributed at low altitudes in plains and hills of North, East and Central China. S. miltiordsrhiza is widely used in most regions of China, including some minority regions such as Inner Mongolia, and is cultivated on a large scale in Hebei, Henan, Shanxi, Shandong and Sichuan provinces. However, it is not easy to distinguish from some morphologically allied species. The farmers and villagers in rural communities generally seek to collect roots which have the red bark of Salvia species and use them as Danshen. As a result, in some herb markets, Danshen may come from the roots of species other than S. miltiorrhiza, especially in regions where several morphologically allied species are present. For example, the roots of S. bowleyana, known as Nandanshen, are available for purchase and use as Danshen in remote mountain areas of Zhejiang, Jiangxi and Fujian provinces and the roots of S. dabieshanensis and S. paramiltiorrhiza are used as Danshen in Dabie mountain areas of Anhui and Hubei provinces. In our previous studies, the amounts of salvianolic acid B or tanshinone IIA in some species of Salvia met the An ethnopharmacological investigation of medicinal Salvia plants (Lamiaceae) in Chinarequirements of the Chinese Pharmacopoeia 14 but further pharmacological and phytochemical studies in relation to the application of these Danshen related species are needed.
To date, only a few Danshen related species such as S. miltiorrhiza have been studied extensively. Over 50 chemical constituents have been isolated and identified in S. miltiorrhiza, all of which can be classified as either hydrophilic phenolic acids such as salvianolic acid B and lithospermic acid or lipophilic tanshinones such as tanshinones I, IIA, and IIB and cryptotanshinone [15] [16] [17] . Based on modern studies, the most important and frequent clinical application of the roots of S. miltiorrhiza has been in the treatment of heart conditions including angina pectoris, coronary artery spasm and myocardial infarction 6, 7, 18 . However, they have also been used for treating neuroasthenic insomnia, hypertension dysmenorrhea, bone loss and chronic renal failure 17, [19] [20] [21] [22] . Interestingly, the root of S. miltiorrhiza has been shown to reduce voluntary alcohol intake in selectively bred Sardinian alcohol-preferring rats, a finding that suggests it may have potential in treating alcoholism 18 . The aqueous extract has also been shown to inhibit HIV-1 integrase activity in vitro and viral replication in vivo. Since salvianolic acid B and lithospermic acid are the major biologically active constituents, the activity against HIV virus may indicate their potential as novel therapeutic drugs for AIDS 22 .
Another extensively studied Salvia species is S. yunnanensis From which some 40 compounds have been isolated and identified. These include abietane diterpenes (yunnanin A, danshenol C), phenolic acids (yunnaneic acids E-H) and alkaloids (salviamines A-F) [23] [24] [25] [26] [27] . Based on recent pharmacological studies, the roots of S. yunnanensis were shown to prevent scar-derived fibroblast formation 28 and the polyphenols and their derivatives to have potent anti-HIV activity 29, 30 . In addition, the roots of S. yunnanensis were reported to be useful in treating hepatocarcinogenesis 31 .
3.2.2. S. plebeia S. plebeia (Lizhicao in Chinese) is another valuable medicinal plant widely distributed in Iran and throughout South East Asia as far as Eastern Australia. The earliest record of S. plebeia was in the Compendium of Materia Medica (Ming Dynasty, A.D. 1590) to treat snake bite and trauma. In the supplement to the later compendium (Qing Dynasty, A.D. 1765) the plant was said "to clear heat and toxic materials, and to remove heat from blood and diuresis". Results of our ethnopharmacological studies indicate that S. plebia has been used to treat bleeding, perineum edema resulting from hemorrhoids, swollen sore throat, bronchitis, hepatitis, cancer, nephritis and mastitis. In recent decades, about 40 35 ; triterpenes ursolic acid 35 , 2α,3β,24-trihydroxy and 2α,3β-dihydroxyolea-12-en-28-oic acid and oleanic acid 39 ; and other compounds conferyl aldehyde, β-sitosterol 33 , scopoletin, salviaplebeiaside 35 , β-daucosterol 39 and two lignin diesters 42, 43 . Recent pharmacological studies of S. plebeia reveal it displays a variety of biological activities consistent with its extensive use in TCM. First, the aqueous and ethanol extracts inhibit the growth of human gastric carcinoma cell lines, suggesting it acts as a potent immunomodulator 44 . Second, the extract of S. plebeia possesses antiangiogenic, antinociceptive, antiinflammatory, antifungal and antioxidant activities 33, 45, 46 . Third, the homoplantaginin isolated from S. plebeia was reported to be protective against hepatocyte injury 47 . Finally, in combination with other herbal ingredients [the seeds of Plantago asiatica L., the roots of Serissa serissoides (DC.) Druce and the herbs of Viola philipica Cav. Lcons et Descr.], this species has been used to treat urinary tract infections and exhibit significant diuretic, antiblastic, antipyretic, antiinflammatory and antidynous activities 48 .
S. prionitis
Another Salvia species valued in folk medicine for its therapeutic activity is S. prionitis (Honggencao in Chinese), the aerial parts of which have been used to treat cold, cancer, pneumonia, hepatitis and diarrhea. Previous phytochemical investigations revealed the presence of more than 50 secondary metabolites among which abietane diterpenes are the overwhelming majority. . It was reported that some abietane diterpenes in this plant showed significant antitumor activity both in vitro and in vivo. For example, saprorthoquinone showed cytotoxicity against P-388 and L-1210 cultured cells and a therapeutic effect against various ascites tumors in mice In this famous ancient text, S. chinensis was recorded as a treatment for ostealgia and swollen carbuncles. However, our ethnopharmacological investigation revealed that this herbal medicine has been employed to treat breast cancer, liver cancer, stomach cancer and hepatitis.
A phytochemical investigation of S. chinensis revealed over 50 chemical constituents in four classes of compounds: terpenoids (monoterpenoids, sesquiterpenes and triperpenoids), phenolic acids, flavonoids and others. Individual members of each class include: Terpenoids α-boswellic acid 65 , blumenol A, clovane-2β,9α-diol 66 and pinfaenoic acid 67 ; phenolic acids salvianolic acid D 68 , salvianolic acid B 69 , propanoic acid, 3-(3,4-dihydroxyphenyl)-2-hydroxybenzoic acid 70 , 3,5-dimethoxy-4-hydroxybenzoic acid 71 , 5,7,4′-trihydroxydihydroflavonol 71 and protocatechuic acid 72 ; flavonoids 3,5,7-trihydroxychromone and kaempferol 67 ; and other compounds β-sitosterol 65, 73 , 5-hydroxymethyl furaldehyde 73 , syringaresinol 71 and various aldehydes 65, 73 .
Modern pharmacological research has revealed that the aqueous extract of S. chinensis can significantly inhibit the proliferation of human nasopharynx cancer CNE cells and human gastric cancer MGC-803 cells 74 . Polysaccharides isolated from S. chinensis exhibited strong antitumor activity 75, 76 and were also reported to stimulate B-lymphocytes and, at a concentration of 20 mg/L, protect PC-12 cells against H 2 O 2 -induced injury [76] [77] [78] . In addition, S. chinensis was reported to protect against CCl 4 -induced acute liver injury in mice probably due to the antioxidant activity of the phenolic acids present in this herbal medicine 79 . Again this species has not been studied extensively and little is known about the active substances responsible for its bioactivities, especially its anticancer activity.
Other species
Based on our investigations of folk medicines, six Salvia species (S. japonica, S. kiangsiensis, S. liguliloba, S. substolonifera, S. scapiformis and S. coccinea) have been mainly used to clear heat from the blood. The results indicate that Salvia plants may be a source of new drugs possessing antibacterial, antiviral and antitumor activities. The leaves of S. officinalis have been used in tea to prevent and treat hypertension but the bioactivities of its individual chemical constituents remain to be assessed.
Conclusions
Despite the recorded use of 35 Salvia plants in folk medicine, only a few species have been studied extensively and many questions remain in relation to their systematic classification, identification and resource utilization. Nevertheless, it is clear that some species of Salvia L. possess significant potential in the treatment of heart disease. The diterpenoids and the caffeic acid derivatives are the most characteristic compounds in the genus 14, 63 , most of which are associated with antioxidant, anticoagulant and cytoprotective activities. They also possess a wide variety of other activities including anti-ischemia-reperfusion injury, antihypertensive, antifibrotic, antiviral and antitumor activities 22, 32, 80, 81 . However, many species of Salvia remain to be explored in terms of their safety or toxicity and their phytochemical and pharmacological characteristicsin order to improve their medical utilization and develop effective natural drugs.
